Sheryl Stevenson, Eye Care Group Editorial Director

Digital Twin and VESA can integrate refractive data, topography, biomechanical properties, and even simulate age-related changes in the eye—turning it into a predictive and diagnostic tool for clinicians managing complex conditions like presbyopia.

An emerging treatment approach for a commonly underdiagnosed ocular surface disease.

At ASCRS 2025, Alex Hacopian, MD, shares information from his presentation on next-gen presbyopia-correcting intraocular lenses.

Eva Kim, MD, offers valuable insights into why EVO ICL is becoming a compelling alternative to traditional corneal procedures like LASIK.

The starry faculty has a galaxy of symposia planned for May 4, 2025.

The novel corrective eye drop can be prescribed through pharmacy partners BlinkRx or Medvantx.

The May 4 event, themed around Star Wars, will feature the latest innovations, foster open discussions, and provide a collaborative environment for networking and learning, with sessions covering IOLs, oculoplastics, glaucoma, retina therapy, and refractive surgical options.

The new first-line laser treatment for glaucoma and ocular hypertension will be unveiled at the 2025 American Glaucoma Society annual meeting in Washington, DC, from February 26 to March 2.

Bonnie An Henderson, MD, cofounder and program director of EnVision Summit, shares some of the unique qualities of the youth program.

EnVision Summit cofounder and program director Bonnie An Henderson, MD, chats about the new optometry track and what eye care providers can learn from each other.

While no infections or adverse events have been reported, fungal contamination can pose a serious risk of eye infections.

Bonnie An Henderson, MD, shares a few of the emerging trends in eye care she and the faculty plan to tackle at the 2025 EnVision Summit.

Bonnie An Henderson, MD, program director and cofounder of EnVision Summit, shares some background on the meeting, which takes place February 14-17, 2025 in Puerto Rico.

At EyeCon 2024, Analisa Arosemena, MD, discussed the shift away from traditional topical therapies towards more proactive management techniques, aiming to enhance patient outcomes in glaucoma care.

Three resident eye care providers—Khanh Huang, OD; Anupam Garg, MD, PhD; and Shail Patel, MD—were honored with the Visionary in Eye Care award at EyeCon 2024, which recognizes their achievements and contributions during their residency programs.

Adam S. Wenick, MD, PhD, discussed myopia interventions across the lifespan at EyeCon 2024, covering treatments, complications, and prevention strategies.

At EyeCon 2024, Dr. Adam S. Wenick led a symposium on geographic atrophy, covering diagnosis, FDA-approved treatments, and key clinician considerations through case presentations by Dr. Leonard Messner.

Peter J. McDonnell, MD, and Laura M. Periman, MD, discussed innovations in treating ocular surface conditions, emphasizing patient-centered care and interdisciplinary collaboration.

Kelly K. Nichols, OD, MPH, PhD, FAAO, and A. Paul Chous, OD, MA, FAAO, co-chairs of EyeCon 2024, discussed the first day of the conference, which featured talks on thyroid eye disease, refractive technologies, and red flags in patient care.

Laura M. Periman, MD, honorary chair of EyeCon 2024, shares her passion for dry eye disease, discussing her discovery of the Alpenglow Sign in Demodex blepharitis and her insights on research and education for clinicians.

From surgeon to mentor: Smith fuels her commitment to improving glaucoma care by training future ophthalmologists.

Inder Paul Singh, MD, defines what it means to have an interventional mindset when it comes to glaucoma procedures and treatments during the Controversies in Modern Eye Care 2024 meeting.

CIME Cochair Neda Shamie, MD, gives an overview of presentations on Demodex blepharitis, LASIK, retina sessions, and more at this year's conference.

Marc Bloomenstein, OD, FAAO, discusses how optometrists can proactively manage Demodex blepharitis by regularly examining eyelids, diagnosing the condition early, and offering treatments to effectively eradicate the mites and prevent future complications.

Neda Shamie, MD, previews a collaborative day packed with guest speakers, discussions on advanced patient care, and hands-on labs.

Controversies in Modern Eye Care cochair Arjan Hura, MD, details new expansions to the conference's schedule, which include discussions on retina gene therapies, corneal endothelial diseases, and oculoplastics.

Neda Shamie, MD, delves into the evolution of the Controversies in Modern Eye Care meeting, while highlighting what distinguishes it from other conferences.

Marsha Link, PhD, uses three words—Imagine, Prepare, and Optimize—to encourage women to assess their current leadership journey, strategically plan for advancement, and explore new opportunities for growth and impact in vision care.